Dai et al. compared the fluorescence contrast effects of erbium-based rare-earth nanoparticles ErNPs-TRC105 (an antibody to CD105 on tumor vasculatures) with IRDye800-TRC105, which is used in human clinical trials for tumor or sentinel lymph nodes localization [35]. Here, ENG is linked to neoplasm.